Referrals for Newly Diagnosed or T2DM Patients With Inadequate Glycemic Control for Phase III Clinical Trial

Dear Colleague, With the rise of type 2 diabetes (T2DM) amongst pediatric patients, it is imperative to expand safe and effective treatment options. We are  currently participating as investigators for a Phase III sitagliptin research study for pediatric patients with T2DM. As an investigator, we would like to ask for your help with patient referrals.…

Referrals for T2DM Patients Who Are Not Well-Controlled on Metformin Monotherapy for Phase III Clinical Trial

Dear Colleague, With the rise of type 2 diabetes (T2DM) amongst pediatric patients, it is imperative to expand safe and effective treatment options. We are currently participating as investigators for a Phase III sitagliptin research study for pediatric patients with T2DM who are not well-controlled on metformin monotherapy. As an investigator, we would like to…